SIGNIFICANT FACTORS IN LIFECYCLE MANAGEMENT

 

  • Compound-Enabling.

 

  • Extended proprietary coverage, leveraging the INNERCAP patent portfolio.

 

  • Technological entry barriers.

 

  • Optimize bioavailability.

 

  • Enhance patient compliance.

 

  • Targeted point of active release.

 

  • Product Enhancement.
  • Incompatible complementary materials combined.

 

  • Controlled dissolution profiles.

 

  • pH release coatings.

 

  • Increases options of actives and release profiles to work with in developing improved or new chemical entities.

 

  • Less generic competition and counterfeiting.

 

  • Enhanced drug absorption.